Absolute hemoglobin levels (g/dL) in response to mitapivat treatment
| Measurement . | N . | Mean . | SD . | 25th percentile . | Median . | 75th percentile . |
|---|---|---|---|---|---|---|
| Baseline | 16 | 9.19 | 1.10 | 8.55 | 9.55 | 9.93 |
| 5 mg BID | 16 | 9.53 | 1.22 | 8.43 | 9.80 | 10.43 |
| 20 mg BID | 16 | 9.95 | 1.28 | 9.00 | 10.00 | 10.83 |
| 50 mg BID | 16 | 10.38 | 1.21 | 9.52 | 10.15 | 11.25 |
| 100 mg BID | 9 | 10.06 | 1.00 | 9.30 | 10.30 | 10.80 |
| End of taper | 15 | 9.43 | 1.24 | 8.70 | 9.60 | 10.40 |
| End of study | 15 | 9.64 | 1.33 | 8.65 | 9.60 | 10.60 |
| Measurement . | N . | Mean . | SD . | 25th percentile . | Median . | 75th percentile . |
|---|---|---|---|---|---|---|
| Baseline | 16 | 9.19 | 1.10 | 8.55 | 9.55 | 9.93 |
| 5 mg BID | 16 | 9.53 | 1.22 | 8.43 | 9.80 | 10.43 |
| 20 mg BID | 16 | 9.95 | 1.28 | 9.00 | 10.00 | 10.83 |
| 50 mg BID | 16 | 10.38 | 1.21 | 9.52 | 10.15 | 11.25 |
| 100 mg BID | 9 | 10.06 | 1.00 | 9.30 | 10.30 | 10.80 |
| End of taper | 15 | 9.43 | 1.24 | 8.70 | 9.60 | 10.40 |
| End of study | 15 | 9.64 | 1.33 | 8.65 | 9.60 | 10.60 |